SCHEMBL2637523

SCHEMBL2637523

Cc1ccc(S(=O)(=O)Nc2c(=O)[nH]n3c(=O)cc(-c4ccc(Cl)cc4)[nH]c23)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FFAR4 Q5NUL3 2/20 0.44
MAPT P10636 5/20 0.43
TP53 P04637 2/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
POLB P06746 2/20 0.43
KDM4E B2RXH2 5/20 0.42
ALDH1A1 P00352 5/20 0.42
HPGD P15428 4/20 0.42
GAA P10253 4/20 0.42
CYP2C19 P33261 2/20 0.42
CYP2C9 P11712 1/20 0.42
KDM1A O60341 1/20 0.41
MAOA P21397 1/20 0.41
APP P05067 1/20 0.40
LMNA P02545 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
NPC1 O15118 2/20 0.39
RAB9A P51151 2/20 0.39
HSD17B10 Q99714 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2637571 0.89 ALDH1A1 (0.50) FFAR4MAPTPOLBKDM4EALDH1A1
SCHEMBL2637663 0.89 PGR (0.42) FFAR4MAPTTP53SMN1; SMN2POLB
SCHEMBL2637590 0.74 KDM4E (0.41) MAPTTP53SMN1; SMN2KDM4EALDH1A1
SCHEMBL2637722 0.73 PSD (0.39) MAPTTP53SMN1; SMN2KDM4EALDH1A1
SCHEMBL2637795 0.72 MEN1 (0.44) MAPTTP53SMN1; SMN2POLBKDM4E
SCHEMBL3412133 0.71 KEAP1 (0.46) MAPTSMN1; SMN2POLBALDH1A1GAA
SCHEMBL2637556 0.71 POLB (0.46) MAPTSMN1; SMN2POLBKDM4EALDH1A1
SCHEMBL2637889 0.70 KMT2A (0.46) MAPTPOLBKDM4EALDH1A1HPGD
SCHEMBL2638047 0.69 KDM4A (0.44) MAPTTP53SMN1; SMN2POLBKDM4E
SCHEMBL2637595 0.68 MAPT (0.43) MAPTTP53SMN1; SMN2GAALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2438070-A1 GLYCINE B ANTAGONISTS Merz Pharma GmbH & Co. KGaA (DE) 2012-04-11 EP disclosed
WO-2010139483-A1 GLYCINE B ANTAGONISTS MERZ PHARMA GMBH & CO. KGAA (DE) 2010-12-09 WO disclosed